Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Discover which cash back cards have no fees. Find your ideal card and enjoy rewards without extra costs.
28,185 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
A single fund's exit from Klaviyo set off a ripple effect that shaved a chunk from the stock after earnings. This art...
Pension funds are aggressively loading up on the Vanguard Intermediate-Term Government Bond ETF, a move that highligh...
As retirees gear up for Social Security, a disciplined Roth conversion plan timed before benefits begin can lower tax...
When a family grows from two to three, budgets change fast. This practical guide breaks down costs, savings strategie...
A crypto treasury firm AVAX faced Nasdaq scrutiny but bounced back after a strategic reverse split. This article brea...
Federal Reserve staff are more worried about stock prices than tech debt as AI-driven spending drives bond issuance a...
In 2025, local investors outpace builders in delivering starter homes, signaling a shift in how affordable housing re...
The latest Goldman Sachs retirement survey finds a gap between savers’ targets and retirees’ realities, prompting a c...
The Vatican issues Magnifica Humanitas, a landmark call for AI regulation and human-centric design. Anthropic partici...
SpaceX's much-anticipated IPO is expected to deliver a first-day surge that could surpass historic records. Valued ar...
Micron’s shares fell about 12% at the open amid a broad market rout. Yet analysts see a longer-term memory shortage d...